These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
470 related articles for article (PubMed ID: 15283244)
1. Antifungal susceptibility of 50 Candida isolates from invasive mycoses in Chile. Silva V; Alvarado D; Diaz MC Med Mycol; 2004 Jun; 42(3):283-5. PubMed ID: 15283244 [TBL] [Abstract][Full Text] [Related]
2. Susceptibility profile of 200 bloodstream isolates of Candida spp. collected from Brazilian tertiary care hospitals. Colombo AL; Nakagawa Z; Valdetaro F; Branchini ML; Kussano EJ; Nucci M Med Mycol; 2003 Jun; 41(3):235-9. PubMed ID: 12964715 [TBL] [Abstract][Full Text] [Related]
3. The patterns of colonization and antifungal susceptibility of Candida, isolated from preterm neonates in Khorramabad, South West of Iran. Kooshki P; Rezaei-Matehkolaei A; Mahmoudabadi AZ J Mycol Med; 2018 Jun; 28(2):340-344. PubMed ID: 29530715 [TBL] [Abstract][Full Text] [Related]
4. In vitro susceptibility of 545 isolates of Candida spp. to four antifungal agents. Arias A; Arévalo MP; Andreu A; Rodríguez C; Sierra A Mycoses; 1994; 37(7-8):285-9. PubMed ID: 7739661 [TBL] [Abstract][Full Text] [Related]
5. [Susceptibility of yeasts to antifungal agents in Kaunas University of Medicine Hospital]. Skrodeniene E; Dambrauskiene A; Vitkauskiene A Medicina (Kaunas); 2006; 42(4):294-9. PubMed ID: 16687901 [TBL] [Abstract][Full Text] [Related]
6. Fluconazole and itraconazole susceptibility of vaginal yeast isolates from Slovakia. Sojakova M; Liptajova D; Borovsky M; Subik J Mycopathologia; 2004 Feb; 157(2):163-9. PubMed ID: 15119851 [TBL] [Abstract][Full Text] [Related]
7. Species distribution and antifungal susceptibility of Candida bloodstream isolates in a tertiary medical center in Israel. Samra Z; Yardeni M; Peled N; Bishara J Eur J Clin Microbiol Infect Dis; 2005 Sep; 24(9):592-5. PubMed ID: 16172856 [TBL] [Abstract][Full Text] [Related]
8. [In vitro activity of amphotericin B, fluconazole and itraconazole against Candida glabrata strains isolated from clinical samples]. Hüseyin A; Sancak B; Arikan S Mikrobiyol Bul; 2007 Apr; 41(2):235-44. PubMed ID: 17682710 [TBL] [Abstract][Full Text] [Related]
9. Prevalence and antifungal susceptibility of Candida species in a tertiary care hospital in Islamabad, Pakistan. Tasneem U; Siddiqui MT; Faryal R; Shah AA J Pak Med Assoc; 2017 Jul; 67(7):986-991. PubMed ID: 28770873 [TBL] [Abstract][Full Text] [Related]
10. In vitro susceptibility of Candida albicans clinical isolates to eight antifungal agents in Ouagadougou (Burkina Faso). Zida A; Yacouba A; Bamba S; Sangare I; Sawadogo M; Guiguemde T; Kone S; Traore LK; Ouedraogo-Traore R; Guiguemde RT J Mycol Med; 2017 Dec; 27(4):469-475. PubMed ID: 28754462 [TBL] [Abstract][Full Text] [Related]
11. Candida spp. in vitro susceptibility profile to four antifungal agents. Resistance surveillance study in Venezuelan strains. Panizo MM; Reviákina V; Dolande M; Selgrad S Med Mycol; 2009 Mar; 47(2):137-43. PubMed ID: 18651308 [TBL] [Abstract][Full Text] [Related]
12. Antifungal susceptibility of Candida isolates at one institution. Katsuragi S; Sata M; Kobayashi Y; Miyoshi T; Yamashita Y; Neki R; Horiuchi C; Yamanaka K; Kamiya C; Iwanaga N; Tanaka H; Ikeda T; Yoshimatsu J Med Mycol J; 2014; 55(1):E1-7. PubMed ID: 24682093 [TBL] [Abstract][Full Text] [Related]
13. In vitro susceptibility of oral Candida to seven antifungal agents. Kuriyama T; Williams DW; Bagg J; Coulter WA; Ready D; Lewis MA Oral Microbiol Immunol; 2005 Dec; 20(6):349-53. PubMed ID: 16238594 [TBL] [Abstract][Full Text] [Related]
14. Distribution and antifungal susceptibility of yeasts isolates from intensive care unit patients. Hrabovský V; Takáčová V; Schréterová E; Pastvová L; Hrabovská Z; Čurová K; Siegfried L Folia Microbiol (Praha); 2017 Nov; 62(6):525-530. PubMed ID: 28361459 [TBL] [Abstract][Full Text] [Related]
15. Candida and candidaemia. Susceptibility and epidemiology. Arendrup MC Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246 [TBL] [Abstract][Full Text] [Related]
16. Species distribution, antifungal susceptibility and clonal relatedness of Candida isolates from patients in neonatal and pediatric intensive care units at a medical center in Turkey. Kuzucu C; Durmaz R; Otlu B; Aktas E; Gulcan H; Cizmeci Z New Microbiol; 2008 Jul; 31(3):401-8. PubMed ID: 18843896 [TBL] [Abstract][Full Text] [Related]
17. Monitoring Antifungal Resistance in a Global Collection of Invasive Yeasts and Molds: Application of CLSI Epidemiological Cutoff Values and Whole-Genome Sequencing Analysis for Detection of Azole Resistance in Candida albicans. Castanheira M; Deshpande LM; Davis AP; Rhomberg PR; Pfaller MA Antimicrob Agents Chemother; 2017 Oct; 61(10):. PubMed ID: 28784671 [TBL] [Abstract][Full Text] [Related]
18. [Fluconazole-resistant Candida species from HIV infected patients with recurrent Candida stomatitis: cross resistance to itraconazole and ketoconazole]. Metzger S; Hofmann H Mycoses; 1997; 40 Suppl 1():56-63. PubMed ID: 9417515 [TBL] [Abstract][Full Text] [Related]
19. Antifungal susceptibility of Candida isolates at the American University of Beirut Medical Center. Araj GF; Daher NK; Tabbarah ZA Int J Antimicrob Agents; 1998 Nov; 10(4):291-6. PubMed ID: 9916903 [TBL] [Abstract][Full Text] [Related]
20. In vitro susceptibility of Candida spp. to fluconazole, itraconazole and voriconazole and the correlation between triazoles susceptibility: Results from a five-year study. Lei J; Xu J; Wang T J Mycol Med; 2018 Jun; 28(2):310-313. PubMed ID: 29685520 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]